Javitt Daniel C.
Known title: 10% OwnerCIK: 0001864534
Associated companies
Transaction History
| NRXP | ▼ Sell | Open Market | 8,441 | $13K | 11/30/2022 | View on chart |
| NRXP | ▼ Sell | Open Market | 13,730 | $21K | 11/29/2022 | View on chart |
| NRXP | ▼ Sell | Open Market | 33,018 | $35K | 11/17/2022 | View on chart |
| NRXP | ▼ Sell | Open Market | 133,719 | $136K | 11/16/2022 | View on chart |
| NRXP | ▼ Sell | Open Market | 49,200 | $50K | 11/11/2022 | View on chart |
| NRXP | ▼ Sell | Open Market | 784,063 | $791K | 7/29/2022 | View on chart |
| NRXP | ▼ Sell | Gift | 2,000,000 | $0 | 7/1/2022 | View on chart |
| NRXP | ▼ Sell | Open Market | 86,459 | $56K | 6/7/2022 | View on chart |
| NRXP | ▼ Sell | Open Market | 115,657 | $77K | 6/6/2022 | View on chart |
| NRXP | ▼ Sell | Open Market | 243,596 | $171K | 6/3/2022 | View on chart |
| NRXP | ▼ Sell | Gift | 434,594 | — | 7/16/2021 | View on chart |
| NRXP | ▼ Sell | Gift | 434,594 | — | 7/16/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 28, 2026
Ono Pharmaceutical Rallies 13.9% Amid NRX Partnership
Ono Pharmaceutical shares rose 13.9%, a move likely tied to its ongoing relationship with NRX Pharmaceuticals. This partner's stock performance often influences sentiment around NRX, which is currently trading near its 52-week low. The significant gain in the partner's stock highlights the continued relevance of their collaboration in the market.
Ono Pharmaceutical Rallies 13.9% Amid NRX Partnership. Ono Pharmaceutical shares rose 13.9%, a move likely tied to its ongoing relationship with NRX Pharmaceuticals. This partner's stock performance often influences sentiment around NRX, which is currently trading near its 52-week low. The significant gain in the partner's stock highlights the continued relevance of their collaboration in the market.